Search research articles
Contact Us
Filters
Showing results (111-120 of 137) with videos related to
Page
of 14
Sort By:
Journal of Alzheimer'S Disease : JAD
|
July 22, 2017
Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study
Simone Lista, Nicola Toschi, Filippo Baldacci, et al.
Journal of Neuroinflammation
|
July 31, 2024
Tracking neuroinflammatory biomarkers in Alzheimer's disease: a strategy for individualized therapeutic approaches?
Simone Lista, Bruno P Imbimbo, Margherita Grasso, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
March 29, 2016
Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges
Sid E O'Bryant, Simone Lista, Robert A Rissman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 26, 2015
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study
Michael Ewers, Niklas Mattsson, Lennart Minthon, et al.
Neuropharmacology
|
May 15, 2020
Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery
Harald Hampel, Andrea Vergallo, Filippo Caraci, et al.
International Journal of Molecular Sciences
|
April 3, 2021
Physical Exercise and Alzheimer's Disease: Effects on Pathophysiological Molecular Pathways of the Disease
Susana López-Ortiz, Jose Pinto-Fraga, Pedro L Valenzuela, et al.
The Lancet. Neurology
|
March 4, 2018
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
Bruno Dubois, Stephane Epelbaum, Francis Nyasse, et al.
Journal of Neurochemistry
|
August 11, 2022
Biological determinants of blood-based cytokines in the Alzheimer's disease clinical continuum
Alessandro Galgani, Andrea Vergallo, Nicole Campese, et al.
Biochemical Pharmacology
|
November 27, 2013
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020
Harald Hampel, Simone Lista, Stefan J Teipel, et al.
Dialogues in Clinical Neuroscience
|
October 23, 2019
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer's disease
Harald Hampel, Andrea Vergallo, Mohammad Afshar, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 137) with videos related to
Sort By:
Page
of 14
Journal of Alzheimer'S Disease : JAD
|
July 22, 2017
Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study
Simone Lista, Nicola Toschi, Filippo Baldacci, et al.
Journal of Neuroinflammation
|
July 31, 2024
Tracking neuroinflammatory biomarkers in Alzheimer's disease: a strategy for individualized therapeutic approaches?
Simone Lista, Bruno P Imbimbo, Margherita Grasso, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
March 29, 2016
Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges
Sid E O'Bryant, Simone Lista, Robert A Rissman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 26, 2015
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study
Michael Ewers, Niklas Mattsson, Lennart Minthon, et al.
Neuropharmacology
|
May 15, 2020
Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery
Harald Hampel, Andrea Vergallo, Filippo Caraci, et al.
International Journal of Molecular Sciences
|
April 3, 2021
Physical Exercise and Alzheimer's Disease: Effects on Pathophysiological Molecular Pathways of the Disease
Susana López-Ortiz, Jose Pinto-Fraga, Pedro L Valenzuela, et al.
The Lancet. Neurology
|
March 4, 2018
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
Bruno Dubois, Stephane Epelbaum, Francis Nyasse, et al.
Journal of Neurochemistry
|
August 11, 2022
Biological determinants of blood-based cytokines in the Alzheimer's disease clinical continuum
Alessandro Galgani, Andrea Vergallo, Nicole Campese, et al.
Biochemical Pharmacology
|
November 27, 2013
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020
Harald Hampel, Simone Lista, Stefan J Teipel, et al.
Dialogues in Clinical Neuroscience
|
October 23, 2019
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer's disease
Harald Hampel, Andrea Vergallo, Mohammad Afshar, et al.
Page
of 14